979
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Efficacy of microwave hyperthermia and chemotherapy in the presence of gold nanoparticles: An in vitro study on osteosarcoma

, , , &
Pages 625-636 | Published online: 16 Aug 2011

References

  • ACS: Statistics for 2008. Available at: http://www.cancer.org/docroot/STT/STT_0.asp (accessed 24 June 2008)
  • Shuford K, Schatz G. Optical properties of gold nanospheres. Nanoscape 2005; 2: 27–33
  • Sumer B, Gao J. Theranostic nanomedicine for cancer. Nanomed 2008; 3: 137–140
  • Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small. 2005; 1(3)325–327
  • Hahn GM, Braun J, Har-Kedar I. Thermochemotherapy: Synergism between hyperthermia (42–43°) and Adriamycin (or bleomycin) in mammalian cell inactivation. Proc Nat Acad Sci USA 1975; 72: 937–940
  • Wang G, Gong Yu, Wang H. Schemes of microwave hyperthermia by using flat left-handed material lenses; microwave and optical technology letters. 2009, 51: 1738–1743
  • Overgaard J, Suit HD. Time–temperature relationship in hyperthermic treatment of malignant and normal tissue in vivo. Cancer Research 1979; 39: 3248–3253
  • Magin RL, Sikic B, Cycyk RL. Enhancement of bleomycin activity against Lewis lung tumors in mice by local hyperthermia. Cancer Research 1979; 39: 3792–3795
  • Horsman MR. Tissue physiology and the response to heat. Int J Hyperthermia 2006; 22: 197–203
  • Baronzio GF, Dieter Hager E. Hyperthermia in Cancer Treatment: A Primer (Medical Intelligence Unit). Springer, 2006, 80–176.
  • Iwata K, Shakil A, Hur W-J, Makepeace CM, Griffin RJ, Song CW. Tumour pO2 can be increased markedly by mild hyperthermia. British Journal of Cancer 1996; 27S74: 217–221
  • Vaupel PW, Kelleher DK. Pathophysiological and vascular characteristics of tumours and their importance for hyperthermia: Heterogeneity is the key issue. Int J Hyperthermia 2010; 26: 211–223
  • Vaupel P, Horseman MR. Tumour perfusion and associated physiology: Characterization and significance for hyperthermia. Int J Hyperthermia 2010; 26: 209–210
  • Cheung AY, Neyzari A. Deep local hyperthermia for cancer therapy: External electromagnetic and ultrasound techniques. Cancer Research 1984; 44: S4736–4744
  • Hergt R, Dutz S, Muller R, Zeisberger M. Magnetic particle hyperthermia: Nanoparticles magnetism and materials development for cancer therapy. J Phys: Condens Matter, 2006; 18: 2919–2934
  • Johnsen M, Gneveckow U, Eckelt L, Feussner A, Waldofner N, Scholz R, Deger S, Wust P, Loening SA, Jordan A. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique. Int J Hyperthermia 2005; 21: 637–647
  • Gannon CJ, Patra CR, Bhattacharya R, Mukherjee P, Curley SA. Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells. J Nanobiotechnology 2008; 6: 2
  • Aoyagi N, Takemura N, Takakura K, Kobayashi H. Effects of moderate hyperthermia on the rabbit sarcoma model. Neurol Med Chir (Tokyo) 2003; 43: 105–110; discussion 111
  • Liebergall M, Simkin A, Mendelson S, Rosenthal A, Segal D. Effect of moderate bone hyperthermia on cell viability and mechanical function. Clin Orthop Relat Res 1998; 349: 242–248
  • Liebergall M, Abu-Sneineh CH, Eylon S, Mendelson S, Segal D, Simkin A. Effect of microwave oven induced mild hyperthermia on bone viability and strength. Clin Orthop Relat Res 2000; 372: 272–279
  • Nielsen OS, Dombernowsky P, Mouridsen H, Daugaard S, Van Glabbeke M, Kirkpatrick A, Verweij J. Epirubicin is not superior to Dox in the treatment of advanced soft tissue sarcomas. The experience of the EORTC soft tissue and bone sarcoma group. Sarcoma 2000; 4: 31–35
  • Akaguchi Y, Maehara Y, Emi Y, Kohnoe S, Sugimachi K. Adriamycin combined with hyperthermia and dipyridamole is cytotoxic both in vitro and in vivo. Eur Surg Res 1992; 24: 249–256
  • Wieder ME, Hone DC, Cook MJ, Handsley MM, Gavrilovic J, Russell DA. Intracellular photodynamic therapy with photosensitizer- nanoparticles conjugates: Cancer therapy using a Trojan horse. Photochem Photobiol Sci 2006; 5: 727–734
  • Sukiyama I, Ogino T, Egawa S. Hyperthermia for bone and soft tissue sarcoma: Relationship between computerized tomographic and histological findings. Radiat Med 1994; 12: 231–236
  • Moran CH, Wainerdi SM, Tonya K, Cherukuri TK, Kittrell C, Wiley BJ, Nicholas NW, Curley SA, Kanzius JS, Cherukuri P. Size-dependent joule heating of gold nanoparticles using capacitively coupled radiofrequency fields. Nano Res 2009; 2: 400–405
  • Wondergem J, Stephens LC, Strebel FR, Baba H, Ohno S, Siddik ZH, Newman RA, Bull JM. Effect of Adriamycin combined with whole body hyperthermia on tumor and normal tissues. Cancer Research 1991; 51: 3559–3567
  • Li GC. Thermal biology and physiology in clinical hyperthermia: Current status and future needs. Cancer Res 1984; 44: S4886–4893
  • Ichinoseki-Sekine N, Naito H, Saga N, Ogura Y, Shiraishi M, Giombini A, Giovannini V, Katamot S. Effects of microwave hyperthermia at two different frequencies (434 and 2450 MHz) on human muscle temperature. J Sports Sci Med 2008; 7: 191–193
  • Niidome T, Yamagata M, Okamoto Y, Akiyama Y, Takahashi H, Kawano T, Katayama Y, Niidome Y. PEG-modified gold nanorods with a stealth character for in vivo applications. J Control Release 2006; 114: 343–347
  • Chithrani BD, Ghazani AA, Chan WC. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006; 6: 662–668
  • Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy JA, Atala A, Mukhopadhyay D, Soker S. Antiangiogenic properties of gold nanoparticles. Clin Cancer Res 2005; 11: 3530–3534
  • Alkilany AM, Murphy CJ, Toxicity and cellular uptake of gold nanoparticles: What we have learned so far. J Nanopart Res 2010; doi 10.1007/s11051-010-9911-8
  • Lasagna-Reeves C, Gonzales-Romero D, Barria MA, Olmedo I, Clos A, Sadagopa Ramanujam VM, Urayama A, Vergara L, Kogan MJ, Soto C. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Comm 2010; 393: 649–655
  • Ciaravino V, Meltz ML, Erwin DN. Absence of a synergistic effect between moderate-power radio-frequency electromagnetic radiation and adriamycin on cell-cycle progression and sister-chromatid exchange. Bioelectromagnetics 2005; 12: 289–298
  • Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 2004; 49: 309–315
  • O’Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett 2004; 209: 171–176
  • Barni S, Pontiggia P, Bertone V, Vaccarone R, Silvotti MG, Pontiggia E, Mathé G. Hyperthermia-induced cell death by apoptosis in myeloma cells. Biomed Pharmacother 2001; 55: 170–173
  • Pei-yu PU, Ya-zhuo Z, De-hua J. Apoptosis induced by hyperthermia in human glioblastoma cell line and murine glioblastoma. Chin J Cancer Res 2000; 12: 257–262
  • Uesugi S, Yamashita K, Nakashima K, Ito H. Apoptotic cell death induced by local brain hyperthermia in a rat glioma model. Acta Neuropathol 1998; 96: 351–356
  • Kubes J, Svoboda J, Rosina J, Starec M, Fiserova A. Immunological response in the mouse melanoma model after local hyperthermia. Physiol Res 2008; 57: 459–465
  • Jayasundar R, Honess D, Hall LD, Bleehen NM. Simultaneous evaluation of the effects of RF hyperthermia on the intra- and extracellular tumor pH. Magn Reson Med 2000; 43: 1–8
  • Furusawa Y, Tabuchi Y, Takasaki I, Wada S, Ohtsuka K, Kondo T. Gene networks involved in apoptosis induced by hyperthermia in human lymphoma U937 cells. Cell Biol Int 2009; 33: 1253–1262
  • Yuen C, Zheng W, Huang Z. Improving surface-enhanced Raman scattering effect using gold-coated hierarchical polystyrene bead substrates modified with postgrowth microwave treatment. J Biomed Opt 2008; 13: 064040

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.